Strata Skin Sciences Inc. (NASDAQ: SSKN) Stock Information | RedChip

Strata Skin Sciences Inc. (NASDAQ: SSKN) Listen to this Section


$2.55
-0.2200 ( -7.94% ) 7.5K

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

Market Data


Open


$2.55

Previous close


$2.77

Volume


7.5K

Market cap


$10.60M

Day range


$2.56 - $2.77

52 week range


$2.55 - $10.80

Insider Ownership Transactions

Total Amount Purchased: -2,045,735.00 | $ -5,216,624.25

Date Type Amount Purchased Purchaser
2024-07-17 Buy 230573.00 Geiger Uri
2024-07-17 Buy 19100.00 Rafaeli Dolev
2024-07-17 Buy 230573.00 Accelmed Partners, L.P.
2023-12-05 Buy 14338.00 Gov Shmuel
2023-11-22 Sale -337500.00 Lesovitz Christopher
2023-11-22 Sale -416250.00 Gov Shmuel
2023-11-20 Sale -1000.00 Rubinstein Samuel
2023-10-30 Sale -1745569.00 Rafaeli Dolev
2023-10-27 Sale -20000.00 Cafran Wayne
2023-10-27 Sale -20000.00 Yaniv Irit

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 78 Aug 14, 2024
8-k 8K-related 15 Aug 14, 2024
8-k 8K-related 15 Jul 23, 2024
4 Insider transactions 1 Jul 17, 2024
4 Insider transactions 1 Jul 17, 2024
8-k 8K-related 15 Jul 17, 2024
4 Insider transactions 1 Jul 17, 2024
8-k 8K-related 15 Jul 11, 2024
8-k 8K-related 13 Jun 25, 2024
8-k 8K-related 15 Jun 04, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.